(Press-News.org) ATS 2012, SAN FRANCISCO –Weight loss improved both metabolic parameters and sleep-disordered breathing (SDB) in obese children in a new study from researchers in Belgium, confirming links between metabolic dysregulation, SDB and obesity.
"SDB is highly prevalent in childhood obesity, and may be a risk factor for the metabolic syndrome. In our population of 224 obese children and adolescents, 30% had SDB, which was significantly correlated with metabolic parameters, including aspartate aminotransferase (ASAT), alanine aminotransferase (ALAT) and HDL cholesterol at baseline," said Stijn Verhulst, MD, MSc, PhD, coordinator of the pediatric sleep lab at the Antwerp University Hospital, Belgium. "After weight loss, all metabolic parameters improved, and just 24% of the study group had residual SDB."
The results will be presented at the ATS 2012 International Conference in San Francisco.
Median age of the children in the study was 15.5 years (range 10.1-18.0). Participants underwent baseline sleep screening and those with diagnosed SDB underwent additional sleep screening four-six months after weight loss treatment. A fasting blood assay was performed at baseline and at four-six months.
Mean BMI at baseline was 36.4 kg/m2. After a six-month weight loss program that incorporated diet, increased physical activity and psychological support, mean BMI was reduced to 29.2 kg/m2. ASAT improved after weight loss in parallel with an improvement in oxygen saturation during sleep, while HDL-cholesterol mainly improved with lowering BMI.
"The association between SDB and metabolic parameters in children remains controversial," said Dr. Verhulst. "This study confirmed the independent effect of nocturnal hypoxia on HDL-cholesterol and liver enzyme levels in morbidly obese teenagers with SDB at baseline. We also confirmed that weight loss has a high success percentage in the treatment of SDB in obese teenagers. Furthermore, both weight loss and the consequent improvement in SDB both drive improvements in metabolic dysregulation."
"Because of the high dropout rate after six months and the relatively limited number of subjects with residual sleep apnea, these findings need to be confirmed in a larger study," Dr. Verhulst concluded. "Furthermore, it remains important to study the mechanisms linking SDB with these metabolic parameters in obese teens and to study the long-term effects of SDB on future metabolic and cardiovascular morbidity."
###
"Sleep-Disordered Breathing And Metabolic Dysregulation In Obese Children Before And After Weight Loss" (Session D18, Wednesday, May 23, 9:30 a.m., Room 3020-3022, Moscone Center; Abstract 30317)
* Please note that numbers in this release may differ slightly from those in the abstract. Many of these investigations are ongoing; the release represents the most up-to-date data available at press time.
ABSTRACT:
Introduction: A high prevalence of sleep-disordered breathing (SDB) is found in childhood obesity. SDB is a known risk factor for developing the metabolic syndrome. Weight loss has been suggested to be the treatment of choice in obese children.
Aim: In this study we focused on the effects of weight loss and SDB on common metabolic parameters.
Methods: Consecutive obese children between 10 and 18 years were recruited. They followed a treatment program with diet, increased physical activity and psychological support. All children underwent a baseline sleep screening and a control study after 4-6 months of treatment in case of diagnosed SDB. A fasting blood assay was performed baseline and after 4-6 months.
Results: 84 children and adolescents with a median age of 15.1 years (9.5-18.9) were included. Mean BMI z-score was 2.73 ± 0.41. 44% of the subjects had SDB. Respiratory disturbance index correlated with HDL-cholesterol (r=-0.34; P=0.002), ASAT (r=0.33; P=0.003) and ALAT (r=0.35; P=0.001). No correlations were found for glucose, triglycerides and total cholesterol. After weight loss treatment all metabolic parameters improved and only 8% of the patients had residual SDB. Improvements in ASAT and ALAT were mediated by improvements in BMI. Improvements in oxygen desaturation index (ODI) were associated with an increase in HDL-cholesterol (r=0.49; P=0.003).
Conclusion: This study confirms the link between ASAT, ALAT, HDL-cholesterol and SDB baseline. HDL-cholesterol improved after weight loss in association with improvements in ODI.
Funded by: None reported
END
ATS 2012, SAN FRANCISCO –The severity of sleep disordered breathing and nocturnal hypoxemia independently predict both glycosylated hemoglobin (HbA1c) levels and type 2 diabetes mellitus (T2DM), according to a new study.
"Because people with obstructive sleep apnea syndrome (OSAS) are often overweight or obese it has been difficult to interpret earlier studies of the relationship between sleep disordered breathing and metabolic disorders," said Brian Kent, MBBCh, research fellow at St. Vincent's University Hospital in Dublin. "We found that obstructive sleep apnea syndrome ...
Oniqua MRO Analytics (www.oniqua.com), the leading provider of analytics-based MRO optimization solutions for asset-intensive organizations, today announced significant enhancements to its Oniqua Standards Dictionary (OSD) database solution.
Available on an online subscription basis, OSD is a comprehensive material and catalog standards environment specifically designed, built and optimized for asset-intensive industries.
OSD 3.0 maximizes efficiencies in cataloging while minimizing inconsistencies and errors in completed cataloged records. It is designed to assist ...
ATS 2012, SAN FRANCISCO – The number of viral infections during infancy is not associated with wheezing later in childhood, according to a new study from researchers in the Netherlands. While viral illnesses with wheezing in infancy predicted wheezing later in childhood, this association was due in part to decreased neonatal lung function.
"Viral infections in infancy, particularly rhinovirus, are thought to be a risk factor for later asthma development, but it is unclear whether this association is due to the viruses themselves or whether rhinovirus-associated wheeze ...
ATS 2012, SAN FRANCISCO – Prior treatment with inhaled corticosteroids in patients with respiratory disorders who develop community acquired pneumonia (CAP) is associated with a lower incidence and severity of parapneumonic effusion, according to a new study from researchers in Spain.
A parapneumonic effusion is a type of pleural effusion (excess fluid that accumulates between the two pleural layers, the fluid-filled space that surrounds the lungs) that arises as a result of a pneumonia, lung abscess, or bronchiectasis.
"Long-term treatment with inhaled corticosteroids ...
ATS 2012, SAN FRANCISCO – A tiny, resilient metal wire designed to gather and compress diseased lung tissue may offer relief to patients with severe heterogeneous emphysema, a subtype of the disease that involves specific, usually isolated areas of the lungs, according to the results of a multicenter international trial conducted in the Netherlands, Germany and France. The wire, called a lung volume reduction coil (LVRC), can be easily implanted and is designed to take the place of more invasive procedures used to improve the lung function of emphysema patients.
The study ...
ATS 2012, SAN FRANCISCO – Researchers in the United Kingdom have determined that azithromycin, a broad-spectrum antibiotic that also has anti-inflammatory properties, can be an effective treatment option for patients suffering from bronchiolitis obliterans syndrome (BOS), a life-threatening complication that occurs in the majority of patients following lung transplantation.
BOS is the leading cause of mortality after the first year following transplantation, and occurs in part when the body repeatedly rejects the transplanted lung tissue. The syndrome causes the airways ...
ATS 2012, SAN FRANCISCO – Patients with chronic obstructive pulmonary disease (COPD) who become infected with the bacterium Pseudomonas aerguinosa are more likely to have worse clinical outcomes and experience more hospitalizations during the course of their disease than COPD patients who are not infected, according to researchers from Buffalo, N.Y.
The study will be presented at the ATS 2012 International Conference in San Francisco.
Bacterial bronchial infection plays a key role in the course of COPD, causing chronic inflammation as well as acute exacerbations of ...
ATS 2012, SAN FRANCISCO – The expanded use of antiretrovirals, potent drugs used to treat retroviral infections such as human immunodeficiency virus (HIV), has been linked to significant decreases in hospital mortality rates among severely ill HIV-positive(HIV+) patients nationwide, primarily due to a decrease in opportunistic infections, according to a new study by researchers at Stanford University. Despite these encouraging data, the study also revealed that in this population, chronic diseases and bloodstream infections are on the rise.
The study results will be presented ...
OAK BROOK, Ill. – Magnetic resonance imaging (MRI) provides an indication of a breast tumor's response to pre-surgical chemotherapy significantly earlier than possible through clinical examination, according to a new study published online in the journal Radiology.
Women with breast cancer often undergo chemotherapy prior to surgery. Research has shown that women who receive this treatment, known as neoadjuvant chemotherapy, are more likely to achieve breast conservation than those receiving chemotherapy after surgery.
Clinicians track a patient's response to neoadjuvant ...
Researchers at New York University and Albert Einstein College of Medicine of Yeshiva University have discovered new ways neurons work together to ease the transition between sleep and wakefulness. Their findings, which appear in the journal Neuron, provide additional insights into sleep-wake patterns and offer methods to explore what may disrupt them.
Their study explored the biological, or circadian, clocks of Drosophila fruit flies, which are commonly used for research in this area. This is because it is relatively easy to find mutants with malfunctioning biological ...
